TUMOUR NECROSIS FACTOR RECEPTOR-ASSOCIATED PERIODIC SYNDROME

This adverse event was reported 60 times

These drugs are most commonly taken by patients reporting TUMOUR NECROSIS FACTOR RECEPTOR-ASSOCIATED PERIODIC SYNDROME:

# Drug Count
0 CANAKINUMAB 27
1 ETANERCEPT 21
2 PREDNISONE 16
3 ANAKINRA 15
4 CELECOXIB 9
5 LORAZEPAM 9
6 METHOTREXATE 9
7 METHOTREXATE SODIUM 9
8 IBUPFROFEN 8
9 IBUPROFEN 8
See all common drugs associated with TUMOUR NECROSIS FACTOR RECEPTOR-ASSOCIATED PERIODIC SYNDROME

TUMOUR NECROSIS FACTOR RECEPTOR-ASSOCIATED PERIODIC SYNDROME is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ACID REDUCER 1 0.0039
1 SILVER SULFADIAZINE 7 0.0030
2 FAMOTIDINE 20MG 1 0.0027
3 CANAKINUMAB 27 0.0025
4 BARICITINIB 7 0.0023
5 ANAKINRA 15 0.0009
6 TOFACITINIB CITRATE 7 0.0005
7 NALTREXONE HYDROCHLORIDE AND BUPROPION HYDROCHLORIDE 3 0.0004
8 FLUOROMETHOLONE 1 0.0003
9 COLCHICINE 7 0.0003
See all drugs enriched for association with TUMOUR NECROSIS FACTOR RECEPTOR-ASSOCIATED PERIODIC SYNDROME